Insulet Corporation PODD reported second-quarter adjusted earnings of $1.17 per share, beating the consensus of 92 cents.PODD shares are rallying today. Track live prices here.The automated insulin delivery technology maker reported sales of $649.1 million, up 32.9% year over year (31.3% in constant currency), beating the consensus of $612.22 million, exceeding the high end of the company’s guidance range of 26% in constant currency.Total Omnipod revenue of $639 million, up 33.0%, or 31.4% in constant curre ...